New York Valves 2026 to unveil late-breaking research in structural heart disease
Meeting Announcement
Updates every hour. Last Updated: 22-Jun-2026 16:16 ET (22-Jun-2026 20:16 GMT/UTC)
The Cardiovascular Research Foundation® (CRF®) announced the highly anticipated lineup of late-breaking research to be presented at New York Valves: The Structural Heart SummitTM. The premier educational meeting for the structural heart community will take place June 24-26, 2026, at the Jacob K. Javits Convention Center, North in New York, NY.
An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic patients before symptoms occur, according to a study published June 2nd in the open access journal PLOS Medicine by Huangdong Li from the Guangdong Provincial Clinical Research Center for Ocular Diseases in Guangzhou, China, and colleagues.
Women with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer.
Now, researchers at UC San Francisco and UC Berkeley have found a way to help reduce the wait and the worry by using AI to quickly identify those who are most likely to have the disease. By triaging these patients, the AI-guided workflow takes women with abnormal scans through the diagnostic process — from imaging to evaluation and sometimes even biopsy — in a single day.
Since its founding more than a century ago, the Boyce Thompson Institute (BTI) has been a place where bold scientific ideas take root. From advancing plant science and training future researchers, to fostering entrepreneurship and innovation, BTI has long served as a launchpad for scientific discovery. That legacy continues today with innovation extending far beyond the walls of the Institute — and across the globe.
One of the latest examples is PrecizionIQ, an India-based health technology startup co-founded by BTI alumnus Pedro Rodrigues, a former postdoctoral researcher in the lab of Frank Schroeder at BTI. The company is developing novel, non-invasive diagnostics for fetal chromosomal abnormalities, with a mission to make early prenatal testing more accurate, affordable and accessible.